Impact of health management on medication adherence and blood pressure and blood glucose indices in elderly patients with hypertension and diabetes mellitus.
{"title":"Impact of health management on medication adherence and blood pressure and blood glucose indices in elderly patients with hypertension and diabetes mellitus.","authors":"Hong Yang, Junhua Hu, Ting Deng, Ting Li","doi":"10.1007/s12020-025-04249-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The occurrence of hypertension combined with diabetes can lead to a continuous deterioration in the physical condition of elderly patients. Health management, as an indispensable part of medical services, can achieve early prevention of diseases, early treatment of existing conditions, and the integration of prevention and treatment.</p><p><strong>Objective: </strong>We aimed to explore the impact of health management on blood pressure and blood glucose levels, health knowledge mastery, medication adherence, self-management abilities, and quality of life in elderly patients with hypertension (HTN) and diabetes mellitus (DM).</p><p><strong>Methods: </strong>One hundred and fifty elderly patients with HTN and DM who underwent physical examinations from January 2022 to December 2023 were enrolled. Those who received routine health management from January 2022 to December 2022 were assigned to the control group, while those who received comprehensive health management from January 2023 to December 2023 were assigned to the observation group, with 75 patients in each group. Key outcomes were compared, including lipid profiles, blood pressure, glycosylated hemoglobin, fasting plasma glucose, 2-hour postprandial blood glucose, the time taken for physical examinations, patient compliance rates, and physical examination accuracy rates, disease-related knowledge scores, self-management capacity through ESCA scale, quality of life through DSQL scale, and medication adherence through MMAS-8 scale.</p><p><strong>Results: </strong>The observation group demonstrated lower lipid levels, blood pressure, and glycemic indices, along with improved examination efficiency, higher disease knowledge scores, higher ESCA scale and MMAS-8 scale scores, and lower DSQL scale scores than the control group (P < 0.01).</p><p><strong>Conclusion: </strong>Providing health management to elderly patients with HTN and DM significantly reduced blood lipid, blood pressure, and blood glucose levels, improve patients' self-management ability, quality of life, and medication adherence, thereby contributing to disease management.</p>","PeriodicalId":49211,"journal":{"name":"Endocrine","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12020-025-04249-0","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The occurrence of hypertension combined with diabetes can lead to a continuous deterioration in the physical condition of elderly patients. Health management, as an indispensable part of medical services, can achieve early prevention of diseases, early treatment of existing conditions, and the integration of prevention and treatment.
Objective: We aimed to explore the impact of health management on blood pressure and blood glucose levels, health knowledge mastery, medication adherence, self-management abilities, and quality of life in elderly patients with hypertension (HTN) and diabetes mellitus (DM).
Methods: One hundred and fifty elderly patients with HTN and DM who underwent physical examinations from January 2022 to December 2023 were enrolled. Those who received routine health management from January 2022 to December 2022 were assigned to the control group, while those who received comprehensive health management from January 2023 to December 2023 were assigned to the observation group, with 75 patients in each group. Key outcomes were compared, including lipid profiles, blood pressure, glycosylated hemoglobin, fasting plasma glucose, 2-hour postprandial blood glucose, the time taken for physical examinations, patient compliance rates, and physical examination accuracy rates, disease-related knowledge scores, self-management capacity through ESCA scale, quality of life through DSQL scale, and medication adherence through MMAS-8 scale.
Results: The observation group demonstrated lower lipid levels, blood pressure, and glycemic indices, along with improved examination efficiency, higher disease knowledge scores, higher ESCA scale and MMAS-8 scale scores, and lower DSQL scale scores than the control group (P < 0.01).
Conclusion: Providing health management to elderly patients with HTN and DM significantly reduced blood lipid, blood pressure, and blood glucose levels, improve patients' self-management ability, quality of life, and medication adherence, thereby contributing to disease management.
期刊介绍：
Well-established as a major journal in today’s rapidly advancing experimental and clinical research areas, Endocrine publishes original articles devoted to basic (including molecular, cellular and physiological studies), translational and clinical research in all the different fields of endocrinology and metabolism. Articles will be accepted based on peer-reviews, priority, and editorial decision. Invited reviews, mini-reviews and viewpoints on relevant pathophysiological and clinical topics, as well as Editorials on articles appearing in the Journal, are published. Unsolicited Editorials will be evaluated by the editorial team. Outcomes of scientific meetings, as well as guidelines and position statements, may be submitted. The Journal also considers special feature articles in the field of endocrine genetics and epigenetics, as well as articles devoted to novel methods and techniques in endocrinology.
Endocrine covers controversial, clinical endocrine issues. Meta-analyses on endocrine and metabolic topics are also accepted. Descriptions of single clinical cases and/or small patients studies are not published unless of exceptional interest. However, reports of novel imaging studies and endocrine side effects in single patients may be considered. Research letters and letters to the editor related or unrelated to recently published articles can be submitted.
Endocrine covers leading topics in endocrinology such as neuroendocrinology, pituitary and hypothalamic peptides, thyroid physiological and clinical aspects, bone and mineral metabolism and osteoporosis, obesity, lipid and energy metabolism and food intake control, insulin, Type 1 and Type 2 diabetes, hormones of male and female reproduction, adrenal diseases pediatric and geriatric endocrinology, endocrine hypertension and endocrine oncology.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
